In a bold move to accelerate pandemic research, the UK is set to conduct the world’s first controlled COVID-19 human challenge study. Up to 90 volunteers aged 18–30 will be intentionally exposed to the virus in a secure clinical environment, aiming to deepen understanding of infection dynamics and immune responses.
Why It Matters
These trials could unlock critical insights into vaccine efficacy and antiviral therapies, offering a faster pathway to combat emerging variants. Participants will be monitored 24/7 and receive £4,500 compensation after a 14-day quarantine.
Ethics & Safety First
Ethical reviews and medical oversight ensure minimal risk, with only healthy, low-risk individuals eligible. Critics question the approach, but researchers argue the data could save millions of lives globally.
What’s Next?
If approved, trials start next month. The World Health Organization calls it \"a high-stakes gamble with unprecedented scientific potential.\" Results could reshape pandemic preparedness strategies worldwide.
Reference(s):
cgtn.com
